文献速递术前评估与围术期医学

围术期苯二氮䓬类药物对术后恶心呕吐影响的系统评价与Meta分析

The effect of perioperative benzodiazepine administration on postoperative nausea and vomiting: a systematic review and meta-analysis of randomised controlled trials.
PubMed 文献 · Br J Anaesth · 2024-01-04

该系统评价与Meta分析纳入119项RCT,比较苯二氮䓬类与非苯二氮䓬类对照在成人住院手术中的效果。基于中等确定性证据,围术期苯二氮䓬类给药降低PONV、术后恶心和术后呕吐的发生率。

要点

  • 围术期苯二氮䓬类降低PONV(RR 0.77,NNT 16,中等确定性)。
  • 术后恶心RR 0.72(NNT 21),术后呕吐RR 0.74(NNT 55)。
  • 结果为未来PONV预防指南提供依据,但需权衡潜在不良反应。

核心结论

  • 中等质量证据表明围术期苯二氮䓬类给药降低PONV发生率。
  • 该系统评价与Meta分析结果将用于指导未来临床实践指南。

研究设计与样本

  • 系统评价与Meta分析,纳入所有语言的RCT,比较苯二氮䓬类与非苯二氮䓬类对照在成人住院手术中的效果。
  • 使用Cochrane偏倚风险工具评估RCT,随机效应模型合并数据,GRADE评估证据质量。
  • 方案已在PROSPERO预注册(CRD42022361088)并发表于BMJ Open(PMID 31831540)。

主要发现

  • 围术期苯二氮䓬类降低PONV发生率(52项研究,n=5086,RR 0.77,95%CI 0.66-0.89;NNT 16;中等确定性)。
  • 降低术后恶心发生率(55项研究,n=5916,RR 0.72,95%CI 0.62-0.83;NNT 21;中等确定性)。
  • 降低术后呕吐发生率(52项研究,n=5909,RR 0.74,95%CI 0.60-0.91;NNT 55;中等确定性)。

临床怎么用

  • 成人住院手术围术期可考虑苯二氮䓬类用于PONV预防,证据确定性中等。
  • 临床决策需结合患者个体情况权衡苯二氮䓬类潜在不良反应。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Despite recent systematic reviews suggesting their benefit for postoperative nausea, vomiting, or both (PONV) prevention, benzodiazepines have not been incorporated into guidelines for PONV prophylaxis because of concerns about possible adverse effects. We conducted an updated meta-analysis to inform future practice guidelines. METHODS: We included randomised controlled trials (RCTs) of all languages comparing benzodiazepines with non-benzodiazepine comparators in adults undergoing inpatient surgery. Our outcomes were postoperative nausea, vomiting, or both. We assessed risk of bias for RCTs using the Cochrane Risk of Bias tool. We pooled data using a random-effects model and assessed the quality of evidence for each outcome using the Grading of Recommendations, Assessment, Development and Evaluation (GRADE) approach. RESULTS: We screened 31 413 abstracts and 950 full texts. We included 119 RCTs; 104 were included in quantitative synthesis. Based on moderate certainty evidence, we found that perioperative benzodiazepine administration reduced the incidence of PONV (52 studies, n=5086, relative risk [RR]: 0.77, 95% confidence interval [CI] 0.66-0.89; number needed to treat [NNT] 16; moderate certainty), postoperative nausea (55 studies, n=5916, RR: 0.72, 95% CI 0.62-0.83; NNT 21; moderate certainty), and postoperative vomiting (52 studies, n=5909, RR: 0.74, 95% CI 0.60-0.91; NNT 55; moderate certainty). CONCLUSIONS: Moderate quality evidence shows that perioperative benzodiazepine administration decreases the incidence of PONV. The results of this systematic review and meta-analysis will inform future clinical practice guidelines. SYSTEMATIC REVIEW PROTOCOL: The protocol for this systematic review was pre-registered with PROSPERO International Prospective Register of Systematic Reviews (CRD42022361088) and published in BMJ Open (PMID 31831540).

来源:Br J Anaesth,查看原文。版权归原作者所有。

引用

  1. Au E, Zhao K, Belley-Côté E, et al. The effect of perioperative benzodiazepine administration on postoperative nausea and vomiting: a systematic review and meta-analysis of randomised controlled trials. Br J Anaesth. 2024. PMID: 38177006. doi:10.1016/j.bja.2023.11.045

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。